Evidence map›Paper›PMID 39845289›Full record

ArticleJAMIA open2025

Evaluating dimensionality reduction of comorbidities for predictive modeling in individuals with neurofibromatosis type 1.

Aditi Gupta, Ethan Hillis, Inez Y Oh, Stephanie M Morris, Zach Abrams, Randi E Foraker, David H Gutmann, Philip R O Payne

Abstract read
In one paragraph

Article in JAMIA open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Observational
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aditi GuptaInstitute for Informatics, Data Science and Biostatistics, Washington University, Saint Louis, MO 63110, United States.
Ethan HillisInstitute for Informatics, Data Science and Biostatistics, Washington University, Saint Louis, MO 63110, United States.
Inez Y OhInstitute for Informatics, Data Science and Biostatistics, Washington University, Saint Louis, MO 63110, United States.ORCID https://orcid.org/0000-0002-0780-8710
Stephanie M MorrisCenter for Autism Services, Science, and Innovation (CASSI), Kennedy Krieger Institute, Baltimore, MD 21205, United States.
Zach AbramsInstitute for Informatics, Data Science and Biostatistics, Washington University, Saint Louis, MO 63110, United States.
Randi E ForakerInstitute for Informatics, Data Science and Biostatistics, Washington University, Saint Louis, MO 63110, United States.
David H GutmannDepartment of Neurology, School of Medicine, Washington University, Saint Louis, MO 63110, United States.
Philip R O PayneInstitute for Informatics, Data Science and Biostatistics, Washington University, Saint Louis, MO 63110, United States.ORCID https://orcid.org/0000-0002-9532-2998

Funding

Personalized risk assessment in Neurofibromatosis Type 1R01NS131112 · NINDS · WASHINGTON UNIVERSITY · PI Aditi Gupta, PHILIP R.O. PAYNE · 2023 to 2026
$2.2M
NINDS NIH HHS R01 NS131112
6 · The paper itself

Abstract

Objective: Dimensionality reduction techniques aim to enhance the performance of machine learning (ML) models by reducing noise and mitigating overfitting. We sought to compare the effect of different dimensionality reduction methods for comorbidity features extracted from electronic health records (EHRs) on the performance of ML models for predicting the development of various sub-phenotypes in children with Neurofibromatosis type 1 (NF1). Materials and Methods: EHR-derived data from pediatric subjects with a confirmed clinical diagnosis of NF1 were used to create 10 unique comorbidities code-derived feature sets by incorporating dimensionality reduction techniques using raw International Classification of Diseases codes, Clinical Classifications Software Refined, and Phecode mapping schemes. We compared the performance of logistic regression, XGBoost, and random forest models utilizing each feature set. Results: XGBoost-based predictive models were most successful at predicting NF1 sub-phenotypes. Overall, features based on domain knowledge-informed mapping schema performed better than unsupervised feature reduction methods. High-level features exhibited the worst performance across models and outcomes, suggesting excessive information loss with over-aggregation of features. Discussion: Model performance is significantly impacted by dimensionality reduction techniques and varies by specific ML algorithm and outcome being predicted. Automated methods using existing knowledge and ontology databases can effectively aggregate features extracted from EHRs. Conclusion: Dimensionality reduction through feature aggregation can enhance the performance of ML models, particularly in high-dimensional datasets with small sample sizes, commonly found in EHRs health applications. However, if not carefully optimized, it can lead to information loss and data oversimplification, potentially adversely affecting model performance.

Indexed as

clinical research informaticselectronic health recordsneurofibromatosis type 1predictive modeling

Identifiers

PMID39845289
PMCPMC11752863

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.